Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Yield10 Bioscience, Inc. (YTENQ)

0.0150
0.0000
(0.00%)
At close: April 30 at 4:00:00 PM EDT
Loading Chart for YTENQ
  • Previous Close 0.0000
  • Open 0.0150
  • Bid 0.1500 x --
  • Ask 0.1800 x --
  • Day's Range 0.0150 - 0.0150
  • 52 Week Range 0.0010 - 7.1599
  • Volume 250
  • Avg. Volume 247
  • Market Cap (intraday) 10,390
  • Beta (5Y Monthly) -0.01
  • PE Ratio (TTM) --
  • EPS (TTM) -20.1400
  • Earnings Date May 13, 2025 - May 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. On December 6, 2024, Yield10 Bioscience, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

www.yield10bio.com

29

Full Time Employees

December 31

Fiscal Year Ends

Recent News: YTENQ

View More

Performance Overview: YTENQ

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

YTENQ
95.19%
S&P 500 (^GSPC)
5.31%

1-Year Return

YTENQ
99.74%
S&P 500 (^GSPC)
10.59%

3-Year Return

YTENQ
99.98%
S&P 500 (^GSPC)
34.78%

5-Year Return

YTENQ
99.99%
S&P 500 (^GSPC)
91.22%

Compare To: YTENQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: YTENQ

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    10.39k

  • Enterprise Value

    2.07M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.01

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.55

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -178.11%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    750k

  • Net Income Avi to Common (ttm)

    -12.7M

  • Diluted EPS (ttm)

    -20.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    733k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.69M

Research Analysis: YTENQ

View More

Company Insights: YTENQ

Research Reports: YTENQ

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.